Panbela Therapeutics Cash Flow Statement 2019-2024 | PBLA

Fifteen years of historical annual cash flow statements for Panbela Therapeutics (PBLA).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-25.26$-34.93$-10.14$-4.77$-6.20
$0$0$0$0$2.08
$0.66$19.10$1.29$1.10$1.20
$0.66$19.10$1.29$1.10$3.27
$0$0$0$0$0
$0$0$0$0$0
$7.06$2.25$0.63$-0.75$0.30
$-5.40$-2.69$-0.29$0.07$-0.17
$-0.65$0.56$1.60$-0.19$0.19
$-25.25$-15.28$-7.25$-3.85$-2.74
$0.40$-0.66$0$0$0
$0$0$0$0$0
$0$0.00$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0.40$-0.66$0$0$0
$-1.65$0$0$-0.86$-0.19
$0$0$0$0.10$0.81
$-1.65$0$0$-0.76$0.62
$27.80$5.35$10.10$11.20$3.16
$27.80$5.35$10.10$11.20$3.16
$0$0$0$0$0
$-0.01$0$0$0$0
$26.14$5.35$10.10$10.44$3.78
$1.29$-10.58$2.85$6.57$1.04
$0.82$1.09$1.29$1.21$1.09
$0$0$0$0$0